Cargando…

Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic

A rapid development and application of assisted reproductive technologies (ARTs) and ovulation-induction drugs may lead to ovarian hyper stimulation syndrome (OHSS). Young age, low body mass index (BMI), polycystic ovarian syndrome (PCOS), previous OHSS, high follicle count, and elevated serum estra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banker, Manish, Garcia-Velasco, Juan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381376/ https://www.ncbi.nlm.nih.gov/pubmed/25838743 http://dx.doi.org/10.4103/0974-1208.153120

Ejemplares similares

OHSS Free Clinic
por: Devroey, P., et al.
Publicado: (2011)

Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
por: Lappas, V, et al.
Publicado: (1999)

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment
por: Fiedler, Klaus, et al.
Publicado: (2012)

Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy
por: Di Guardo, Federica, et al.
Publicado: (2023)

Outpatient Management of Severe Ovarian Hyperstimulation Syndrome (OHSS) with Placement of Pigtail Catheter
por: Abuzeid, M., et al.
Publicado: (2014)

Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)
por: Farkas, Balint, et al.
Publicado: (2020)

Melatonin Ameliorates Ovarian Hyperstimulation Syndrome (OHSS) through SESN2 Regulated Antiapoptosis
por: Zheng, Min, et al.
Publicado: (2023)

New algorithm for OHSS prevention
por: Papanikolaou, Evangelos G, et al.
Publicado: (2011)

Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2015)

Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
por: Sun, Bo, et al.
Publicado: (2021)

Hyponatremia: An Untimely Finding in Ovarian Hyper-Stimulation Syndrome
por: Elmahal, Mohammed, et al.
Publicado: (2021)

Erratum to: Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2016)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)—a retrospective case–control study
por: Nouri, Kazem, et al.
Publicado: (2014)

Nintedanib Treatment After Ovulation is an Effective Therapeutic Strategy for the Alleviation of Ovarian Hyperstimulation Syndrome (OHSS) in a Mouse Model
por: Jiang, Shutian, et al.
Publicado: (2022)

Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention
por: Bushaqer, Nayla J., et al.
Publicado: (2018)

Hyper memory, synaesthesia, savants Luria and Borges revisited
por: Fornazzari, Luis, et al.
Publicado: (2018)

Ovarian Hyperstimulation Syndrome (OHSS) requiring Intensive Care Unit (ICU) admission between 1996-2020 in England, Wales, and Northern Ireland
por: Abbara, Ali, et al.
Publicado: (2022)

Laparoscopic detorsion for bilateral ovarian torsion in a singleton pregnancy with spontaneous ovarian hyperstimulation syndrome
por: Munshi, Sujal, et al.
Publicado: (2014)

Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?
por: Wang, Ya-Qin, et al.
Publicado: (2015)

Are Pregnancy Rates Compromised Following Embryo Freezing to Prevent OHSS?
por: Fitzmaurice, Gerard J, et al.
Publicado: (2008)

Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy
por: Abbara, Ali, et al.
Publicado: (2015)

Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation
por: Raju, Gottumukkala Achyuta Rama, et al.
Publicado: (2013)

Embryo cryopreservation in a case of acute promyelocytic leukemia, incidentally diagnosed during ovarian stimulation for in-vitro fertilization
por: Banker, Manish, et al.
Publicado: (2014)

Predictive factors for recovery time in patients suffering from severe OHSS
por: Nouri, Kazem, et al.
Publicado: (2014)

Are anthropometric data a tool for determining the severity of OHSS? Yes, it could be!
por: Petrenko, Aleksei Petrovich, et al.
Publicado: (2022)

A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS
por: Yanagihara, Yasuho, et al.
Publicado: (2021)

Pregnancy outcome in severe OHSS patients following ascitic/plerural fluid drainage
por: Haas, Jigal, et al.
Publicado: (2014)

Biomarkers identification in follicular fluid of women with OHSS by using UPLC-MS method
por: Wu, Ze, et al.
Publicado: (2023)

Gonadotropin-releasing hormone agonist for ovulation trigger – OHSS prevention and use of modified luteal phase support for fresh embryo transfer
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome
por: Movahedi, Shohreh, et al.
Publicado: (2016)

Zinc finger gene 217 (ZNF217) Promoted Ovarian Hyperstimulation Syndrome (OHSS) through Regulating E(2) Synthesis and Inhibiting Thrombospondin-1 (TSP-1)
por: Zhai, Junyu, et al.
Publicado: (2017)

Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
por: Rabati, Behnaz Khani, et al.
Publicado: (2012)

Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis
por: Datta, Adrija Kumar, et al.
Publicado: (2020)

Treatment results of high dose cabergoline as an adjuvant therapy in six patients with established severe ovarian hyper stimulation syndrome
por: Saharkhiz, Nasrin, et al.
Publicado: (2014)

Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation
por: Aghssa, Malek Mansour, et al.
Publicado: (2015)

Investigating the potential role of swertiamarin on insulin resistant and non-insulin resistant granulosa cells of poly cystic ovarian syndrome patients
por: Belani, Muskaan A., et al.
Publicado: (2023)

Update on the hyper immunoglobulin M syndromes
por: Davies, E Graham, et al.
Publicado: (2010)

An update on the hyper-IgE syndromes
por: Yong, Patrick FK, et al.
Publicado: (2012)

Low risk of OHSS with follitropin delta use in women with different polycystic ovary syndrome phenotypes: a retrospective case series
por: Yacoub, Stephanie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1lir6fhl03nii4p7b3naemrgeo